hamburger-icon INVESTORS AIM RULE 26 Investors At a Glance Financial Highlights Investment Case CEO Q&A Share Tools Results, Reports and Presentations Financial Calendar Regulatory News Shareholder Services Corporate Governance Corporate Governance Statement Board of Directors Tax Strategy AIM Rule 26 Investor Contacts Sustainability Newsroom The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies. Last updated 30th September 2021 Download our AIM Rule Statement (PDF) Description of the Business Directors’ Details Board Committees Country of Incorporation and Country of operation Nominated advisor and other key advisors Current constitutional documents Company announcements Financial information Admission Documents Details of Any Other Exchanges or Trading Platforms Number of Securities in Issue Details of Any Restrictions on the Transfer of Securities Whether the company is subject to the UK City Code on Takeovers and Mergers RELATED LINKS ANNUAL REPORT ANNUAL REPORT 2021 Download report (pdf 4.64mb) INVESTORS INVESTMENT CASE Read more SHARE TOOLS SHARE TOOLS View all OUR GLOBAL OFFICES United Kingdom Europe Asia, Pacific and Japan South Africa United States SITE TOOLS Stay In Touch AE Reporting Medical enquiries Terms of use Cookies Privacy policy Privacy Statement for Pharmacovigilance Data UK Gender Pay Gap Report Modern Slavery Statement Access Online Sitemap Consumer Information Obligations Clinigen Terms And Conditions Of Business (Sales) Clinigen Terms And Conditions Of Business (Purchases) Cookie settings FIND A MEDICINE Online services for healthcare professionals Hard to find medicines (Clinigen Direct) Managed Access Programs (Cliniport) Clinigen Products Twitter Linkedin © Copyright 2021 Clinigen Group plc. By Emperor OUR USE OF COOKIES We use cookies to improve your experience. By clicking accept, we will set recommended analytics cookies. AcceptRejectSettings